Bioresorbable splint used for first time, successfully stopped life-threatening tracheobronchomalacia, case featured in New England Journal of Medicine
Every day, their baby stopped breathing, his collapsed bronchus blocking the crucial flow of air to his lungs. April and Bryan Gionfriddo watched helplessly, just praying that somehow the dire predictions weren’t true.
“Quite a few doctors said he had a good chance of not leaving the hospital alive,” says April Gionfriddo, about her now 20-month-old son, Kaiba. “At that point, we were desperate. Anything that would work, we would take it and run with it.”
They found hope at the University of Michigan, where a new, bioresorbable device that could help Kaiba was under development. Kaiba’s doctors contacted Glenn Green, M.D., associate professor of pediatric otolaryngology at the University of Michigan.
Green and his colleague, Scott Hollister, Ph.D., professor of biomedical engineering and mechanical engineering and associate professor of surgery at U-M, went right into action, obtaining emergency clearance from the Food and Drug Administration to create and implant a tracheal splint for Kaiba made from a biopolymer called polycaprolactone.
On February 9, 2012, the specially-designed splint was placed in Kaiba at C.S. Mott Children’s Hospital. The splint was sewn around Kaiba’s airway to expand the bronchus and give it a skeleton to aid proper growth. Over about three years, the splint will be reabsorbed by the body. The case is featured today in the New England Journal of Medicine.
“It was amazing. As soon as the splint was put in, the lungs started going up and down for the first time and we knew he was going to be OK,” says Green.
Green and Hollister were able to make the custom-designed, custom-fabricated device using high-resolution imaging and computer-aided design. The device was created directly from a CT scan of Kaiba’s trachea/bronchus, integrating an image-based computer model with laser-based 3D printing to produce the splint.
The Latest Bing News on:
- Bioresorbable Vascular Scaffolds in the Clinical Settingon November 30, 2020 at 4:01 pm
thus providing the device with increased strength and a prolongation of its resorption process. The most widely investigated BRS is the Absorb® bioresorbable vascular scaffold (BVS). The Absorb ...
- Bioresorbable Vascular Scaffolds in the Clinical Settingon November 28, 2020 at 4:00 pm
The introduction of metallic drug-eluting stents has reduced the risk of restenosis and widened the indications of percutaneous coronary intervention in coronary artery disease. However, the ...
- Bioresorbable polymers push new boundarieson November 23, 2020 at 4:00 pm
acting as the delivery device and the drug. The technology has a patent would result in a product where the drug is the delivery vehicle. Michiel van Alst, whose company produces bioresorbable ...
- The challenges and opportunities of bioresorbable polymers in medical technologyon November 23, 2020 at 4:00 pm
What are the benefits for the patient? Len Czuba: There are about a dozen materials commonly considered as “bioresorbable” but, of these, only a few are commonly used in medical device applications.
- GT Medical Technologies raises $16M to help patients with brain tumorson November 22, 2020 at 9:55 pm
President and CEO of medical device company GT Medical Technologies. It has developed the GammaTile, a "small, bioresorbable, conformable 3D-collagen tile," that is placed directly at the site of the ...
- Abbott's Bioresorbable Stent is Successful in Asia as Market Absorbs Higher Priceson November 21, 2020 at 4:00 pm
At other times, however, they may not be so lucky. It appears as if Abbott experiencing the former phenomenon for its bioresorbable scaffold Absorb. The device is meant to dissolve into the system ...
- What's Next for Bioresorbable Scaffolds?on November 21, 2020 at 4:00 pm
Amaranth Medical's Fortitude sirolimus-eluting bioresorbable scaffold (CE Mark application submitted, not yet approved) showed a high clinical device success rate (98.4%) in studies conducted in ...
- ‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER IIIon November 19, 2020 at 7:15 am
But she also acknowledged that new stent technologies represent a crowded field where devices—particularly those with bioresorbable polymers—have struggled to surpass the performance of approved ...
- Global Tumor Embolization Devices Market Report 2020-2030 - ResearchAndMarkets.comon November 16, 2020 at 9:37 am
In 2019, QXMedical announced its decision to license bioresorbable embolic technology from the University of Minnesota, to be used in tumor embolization devices for cancer and tumor treatment. The ...
- REVA’s Fantom Encore Thin Strut Bioresorbable Scaffold Unveiledon November 13, 2020 at 4:01 pm
This is the company’s third generation of bioresorbable scaffolds, and it is CE Marked in Europe and available in a number of countries. The new device has thinner struts compared to other ...
The Latest Google Headlines on:
The Latest Bing News on:
- 3D Printed Splint Saves Baby’s Lifeon November 18, 2020 at 4:00 pm
Between him and [Doctor Glen Green], an associate professor of Pediatric Otolaryngology, they have created a bioresorbable ... create a 3D model and design a “splint” to help support the ...
- Data Bridge Market Researchon September 6, 2015 at 12:03 am
Global Ear and Nasal Packing Market By Type (Nasal (Injectable, Gel, Dressings (Sponges, Splints, Strips)), Ear (Injectable, Gel, Dressings (Sponges, Splints, Strips))), By Material (Bioresorbable ...